196 related articles for article (PubMed ID: 17663142)
21. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
22. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
[TBL] [Abstract][Full Text] [Related]
24. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
[TBL] [Abstract][Full Text] [Related]
25. A splice variant to PACAP receptor that is involved in spermatogenesis is expressed in astrocytes.
Pilzer I; Gozes I
Ann N Y Acad Sci; 2006 Jul; 1070():484-90. PubMed ID: 16888214
[TBL] [Abstract][Full Text] [Related]
26. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
Costa L; Santangelo F; Li Volsi G; Ciranna L
Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
[TBL] [Abstract][Full Text] [Related]
27. Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development.
Watanabe J; Nakamachi T; Matsuno R; Hayashi D; Nakamura M; Kikuyama S; Nakajo S; Shioda S
Peptides; 2007 Sep; 28(9):1713-9. PubMed ID: 17719696
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent neuroprotective protein (ADNP) in the mouse brains.
Nakamachi T; Ohtaki H; Yofu S; Dohi K; Watanabe J; Hayashi D; Matsuno R; Nonaka N; Itabashi K; Shioda S
Regul Pept; 2008 Jan; 145(1-3):88-95. PubMed ID: 17942168
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
[TBL] [Abstract][Full Text] [Related]
30. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
[TBL] [Abstract][Full Text] [Related]
31. PACAP and VIP prevent apoptosis in schwannoma cells.
Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
[TBL] [Abstract][Full Text] [Related]
32. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
Dejda A; Jozwiak-Bebenista M; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
[TBL] [Abstract][Full Text] [Related]
33. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
34. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.
Hautmann M; Friis UG; Desch M; Todorov V; Castrop H; Segerer F; Otto C; Schütz G; Schweda F
J Am Soc Nephrol; 2007 Apr; 18(4):1150-6. PubMed ID: 17360952
[TBL] [Abstract][Full Text] [Related]
36. Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?
Staines D
Med Hypotheses; 2005; 65(1):29-31. PubMed ID: 15893112
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of a PAC1 receptor hop-1 splice variant in goldfish (Carassius auratus).
Kwok YY; Chu JY; Vaudry H; Yon L; Anouar Y; Chow BK
Gen Comp Endocrinol; 2006 Jan; 145(2):188-96. PubMed ID: 16225877
[TBL] [Abstract][Full Text] [Related]
38. Characterization of four receptor cDNAs: PAC1, VPAC1, a novel PAC1 and a partial GHRH in zebrafish.
Fradinger EA; Tello JA; Rivier JE; Sherwood NM
Mol Cell Endocrinol; 2005 Feb; 231(1-2):49-63. PubMed ID: 15713535
[TBL] [Abstract][Full Text] [Related]
39. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
40. Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update.
Muller JM; Debaigt C; Goursaud S; Montoni A; Pineau N; Meunier AC; Janet T
Peptides; 2007 Sep; 28(9):1655-66. PubMed ID: 17555844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
